本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

35.11
-0.8700-2.42%
盘后36.861.75+4.98%17:01 EDT
成交量:113.67万
成交额:4,080.42万
市值:33.14亿
市盈率:-5.98
高:37.50
开:36.31
低:35.01
收:35.98
数据加载中...
2019/08/14

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/02

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/08/01

重要事件披露

Current report, items 8.01 and 9.01
2019/07/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/09

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/26

超过5%披露

General statement of acquisition of beneficial ownership
2019/06/25

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/24

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/21

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/21

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/20

重要事件披露

Current report, items 8.01 and 9.01
2019/06/17

重要事件披露

Current report, item 5.07
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities